Literature DB >> 7532481

Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegener's granulomatosis and systemic lupus erythematosus.

C Mrowka1, H G Sieberth.   

Abstract

Inflammatory systemic disorders with renal tissue damage require the adherence of polymorphonuclear leukocytes to the endothelium, which is mediated by cell surface adhesion molecules. This study measured the serum concentrations of circulating adhesion molecules [intercellular adhesion molecule 1 (cICAM-1), vascular cell adhesion molecule 1 (cVCAM-1), cE-selectin] by sandwich enzyme-linked immunosorbent assay in Wegener's granulomatosis (n = 25) and systemic lupus erythematosus (n = 50). Active Wegener's granulomatosis with cellular crescent formation was associated with significantly raised cICAM-1 levels, an elevated histological activity index, and a high rate of hemodialysis in comparison to Wegener's granulomatosis with fibrocellular crescents or lupus nephritis. The activity index and cICAM-1 levels can be used as parameters to predict renal outcome in Wegener's granulomatosis. cVCAM-1 levels in Wegener's granulomatosis were significantly higher in patients with hemodialysis compared to those without hemodialysis. In lupus nephritis only cVCAM-1, not cICAM-1 or cE-selectin, were significantly higher (P < 0.01) than controls. cVCAM-1 levels in both diseases were significantly higher than in controls. Only in Wegener's granulomatosis did cICAM-1 and cVCAM-1 levels decrease with clinical remission; in systemic lupus erythematosus the levels remained unchanged. cE-selectin levels were not significantly elevated in systemic vasculitis or collagen disease although individual patients revealed high serum concentrations. These data suggest that levels of circulating adhesion molecules reflect different pathophysiological processes in systemic vasculitis and collagen disease and may be used as markers of disease activity and renal outcome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532481     DOI: 10.1007/bf00180543

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  29 in total

Review 1.  Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance.

Authors:  A J Gearing; I Hemingway; R Pigott; J Hughes; A J Rees; S J Cashman
Journal:  Ann N Y Acad Sci       Date:  1992-12-04       Impact factor: 5.691

2.  Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells.

Authors:  R Pigott; L P Dillon; I H Hemingway; A J Gearing
Journal:  Biochem Biophys Res Commun       Date:  1992-09-16       Impact factor: 3.575

3.  Identification of an inducible endothelial-leukocyte adhesion molecule.

Authors:  M P Bevilacqua; J S Pober; D L Mendrick; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.

Authors:  M P Bevilacqua; S Stengelin; M A Gimbrone; B Seed
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

5.  Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity.

Authors:  J C Becker; R Dummer; A A Hartmann; G Burg; R E Schmidt
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

6.  A form of circulating ICAM-1 in human serum.

Authors:  R Rothlein; E A Mainolfi; M Czajkowski; S D Marlin
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

7.  Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis.

Authors:  J J Cush; R Rothlein; H B Lindsley; E A Mainolfi; P E Lipsky
Journal:  Arthritis Rheum       Date:  1993-08

8.  Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases.

Authors:  D H Adams; E Mainolfi; P Burra; J M Neuberger; R Ayres; E Elias; R Rothlein
Journal:  Hepatology       Date:  1992-09       Impact factor: 17.425

9.  Expression of vascular cell adhesion molecule-1 in kidney allograft rejection.

Authors:  C E Alpers; K L Hudkins; C L Davis; C L Marsh; W Riches; J M McCarty; C D Benjamin; T M Carlos; J M Harlan; R Lobb
Journal:  Kidney Int       Date:  1993-10       Impact factor: 10.612

10.  Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity.

Authors:  W H Schmitt; C Heesen; E Csernok; A Rautmann; W L Gross
Journal:  Arthritis Rheum       Date:  1992-09
View more
  10 in total

Review 1.  Role of proteinase 3 in activation of endothelium.

Authors:  M E Taekema-Roelvink; C van Kooten; C A Verburgh; M R Daha
Journal:  Springer Semin Immunopathol       Date:  2001

2.  von Willebrand factor antigen and adhesive molecules in Wegener's granulomatosis and microscopic polyangiitis.

Authors:  R Becvar; A Paleckova; V Tesar; I Rychlik; Z Masek
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

3.  Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis.

Authors:  Paul A Monach; Roscoe L Warner; Gunnar Tomasson; Ulrich Specks; John H Stone; Linna Ding; Fernando C Fervenza; Barri J Fessler; Gary S Hoffman; David Iklé; Cees G M Kallenberg; Jeffrey Krischer; Carol A Langford; Mark Mueller; Philip Seo; E William St Clair; Robert Spiera; Nadia Tchao; Steven R Ytterberg; Kent J Johnson; Peter A Merkel
Journal:  Ann Rheum Dis       Date:  2012-09-12       Impact factor: 19.103

4.  Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.

Authors:  P Lamprecht; F Moosig; A Gause; K Herlyn; E Csernok; H Hansen; W L Gross
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

5.  Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome.

Authors:  J Krejsek; R Slezák; O Kopecky; V Derner; C Andrys
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

6.  Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE).

Authors:  J Font; P Pizcueta; M Ramos-Casals; R Cervera; M García-Carrasco; M Navarro; M Ingelmo; P Engel
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

7.  Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis.

Authors:  Paul A Monach; Philipp Kümpers; Alexander Lukasz; Gunnar Tomasson; Ulrich Specks; John H Stone; David Cuthbertson; Jeffrey Krischer; Simon Carette; Linna Ding; Gary S Hoffman; David Iklé; Cees G M Kallenberg; Nader A Khalidi; Carol A Langford; Philip Seo; E William St Clair; Robert Spiera; Nadia Tchao; Steven R Ytterberg; Marion Haubitz; Peter A Merkel
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

8.  Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage.

Authors:  A Grothey; P Heistermann; S Philippou; R Voigtmann
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

9.  Mannitol and renal graft injury in patients undergoing deceased donor renal transplantation - a randomized controlled clinical trial.

Authors:  Christian Reiterer; Karin Hu; Samir Sljivic; Markus Falkner von Sonnenburg; Edith Fleischmann; Alexander Kainz; Barbara Kabon
Journal:  BMC Nephrol       Date:  2020-07-28       Impact factor: 2.388

10.  Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis.

Authors:  Huihua Ding; Yiwei Shen; Cheng Lin; Ling Qin; Shijun He; Min Dai; Shinji L Okitsu; Julie A DeMartino; Qiang Guo; Nan Shen
Journal:  Arthritis Res Ther       Date:  2022-03-28       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.